| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 13.585 | 14.251 | 7.578 | 6.442 | 5.067 | 5.166 | 3.832 | 2.648 | 2.131 | 30 |
| Total Income - EUR | 13.585 | 14.251 | 11.956 | 6.442 | 5.067 | 5.317 | 3.832 | 2.648 | 2.131 | 30 |
| Total Expenses - EUR | 13.109 | 15.690 | 8.740 | 8.084 | 7.331 | 7.478 | 6.272 | 5.697 | 5.448 | 1.177 |
| Gross Profit/Loss - EUR | 477 | -1.439 | 3.216 | -1.642 | -2.264 | -2.161 | -2.440 | -3.048 | -3.317 | -1.147 |
| Net Profit/Loss - EUR | -50 | -1.798 | 2.857 | -1.835 | -2.416 | -2.262 | -2.440 | -3.128 | -3.317 | -1.147 |
| Employees | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 1 | 0 |
Check the financial reports for the company - Farmaceutica Vindobona Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 10.300 | 8.368 | 7.197 | 4.167 | 1.600 | 763 | 835 | 1.219 | 600 | 25 |
| Inventories | 10.296 | 7.660 | 6.974 | 4.030 | 1.503 | 645 | 757 | 1.120 | 530 | 0 |
| Receivables | 2 | 2 | 0 | 0 | 0 | 0 | 26 | 40 | 1 | 25 |
| Cash | 2 | 706 | 223 | 137 | 97 | 118 | 52 | 59 | 70 | 0 |
| Shareholders Funds | -946 | -2.735 | 168 | -5.838 | -8.141 | -10.248 | -12.461 | -15.628 | -18.897 | -19.939 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 11.246 | 11.103 | 7.028 | 10.005 | 9.939 | 11.206 | 13.486 | 17.037 | 19.688 | 19.964 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Farmaceutica Vindobona Srl